385 related articles for article (PubMed ID: 15175256)
1. Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin.
Zhang M; Gaschen B; Blay W; Foley B; Haigwood N; Kuiken C; Korber B
Glycobiology; 2004 Dec; 14(12):1229-46. PubMed ID: 15175256
[TBL] [Abstract][Full Text] [Related]
2. N-glycosylation at one rabies virus glycoprotein sequon influences N-glycan processing at a distant sequon on the same molecule.
Wojczyk BS; Takahashi N; Levy MT; Andrews DW; Abrams WR; Wunner WH; Spitalnik SL
Glycobiology; 2005 Jun; 15(6):655-66. PubMed ID: 15677380
[TBL] [Abstract][Full Text] [Related]
3. HIV/SIV glycoproteins: structure-function relationships.
Douglas NW; Munro GH; Daniels RS
J Mol Biol; 1997 Oct; 273(1):122-49. PubMed ID: 9367752
[TBL] [Abstract][Full Text] [Related]
4. HCV E2 glycoprotein: mutagenesis of N-linked glycosylation sites and its effects on E2 expression and processing.
Slater-Handshy T; Droll DA; Fan X; Di Bisceglie AM; Chambers TJ
Virology; 2004 Feb; 319(1):36-48. PubMed ID: 14967486
[TBL] [Abstract][Full Text] [Related]
5. Genetically destined potentials for N-linked glycosylation of influenza virus hemagglutinin.
Igarashi M; Ito K; Kida H; Takada A
Virology; 2008 Jul; 376(2):323-9. PubMed ID: 18456302
[TBL] [Abstract][Full Text] [Related]
6. Molecular evolution of human influenza A viruses in a local area during eight influenza epidemics from 2000 to 2007.
Zaraket H; Saito R; Sato I; Suzuki Y; Li D; Dapat C; Caperig-Dapat I; Oguma T; Sasaki A; Suzuki H
Arch Virol; 2009; 154(2):285-95. PubMed ID: 19153639
[TBL] [Abstract][Full Text] [Related]
7. A single glycosylation site within the receptor-binding domain of the avian sarcoma/leukosis virus glycoprotein is critical for receptor binding.
Delos SE; Burdick MJ; White JM
Virology; 2002 Mar; 294(2):354-63. PubMed ID: 12009877
[TBL] [Abstract][Full Text] [Related]
8. Effect of the addition of oligosaccharides on the biological activities and antigenicity of influenza A/H3N2 virus hemagglutinin.
Abe Y; Takashita E; Sugawara K; Matsuzaki Y; Muraki Y; Hongo S
J Virol; 2004 Sep; 78(18):9605-11. PubMed ID: 15331693
[TBL] [Abstract][Full Text] [Related]
9. [Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins].
Goffard A; Lazrek M; Bocket L; Dewilde A; Hober D
Ann Biol Clin (Paris); 2007; 65(3):237-46. PubMed ID: 17502294
[TBL] [Abstract][Full Text] [Related]
10. [Application of gene sequence cluster in research for H3 antigenic evolution of influenza A virus].
Zhang WT; Jiang QW; Jiang LF; Ju LW
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Dec; 25(12):1046-9. PubMed ID: 15769361
[TBL] [Abstract][Full Text] [Related]
11. Influence of N-linked glycans on intracellular transport of hepatitis C virus E1 chimeric glycoprotein and its role in pseudotype virus infectivity.
Beyene A; Basu A; Meyer K; Ray R
Virology; 2004 Jul; 324(2):273-85. PubMed ID: 15207615
[TBL] [Abstract][Full Text] [Related]
12. Biases and complex patterns in the residues flanking protein N-glycosylation sites.
Ben-Dor S; Esterman N; Rubin E; Sharon N
Glycobiology; 2004 Feb; 14(2):95-101. PubMed ID: 14514714
[TBL] [Abstract][Full Text] [Related]
13. Evolutionary study of hepatitis C virus envelope genes during primary infection.
Chen S; Wang YM
Chin Med J (Engl); 2007 Dec; 120(24):2174-80. PubMed ID: 18167197
[TBL] [Abstract][Full Text] [Related]
14. Deletion of N-glycosylation sites of hepatitis C virus envelope protein E1 enhances specific cellular and humoral immune responses.
Liu M; Chen H; Luo F; Li P; Pan Q; Xia B; Qi Z; Ho WZ; Zhang XL
Vaccine; 2007 Sep; 25(36):6572-80. PubMed ID: 17675185
[TBL] [Abstract][Full Text] [Related]
15. The hemagglutinin structure of an avian H1N1 influenza A virus.
Lin T; Wang G; Li A; Zhang Q; Wu C; Zhang R; Cai Q; Song W; Yuen KY
Virology; 2009 Sep; 392(1):73-81. PubMed ID: 19628241
[TBL] [Abstract][Full Text] [Related]
16. Concanavalin A binding to HIV envelope protein is less sensitive to mutations in glycosylation sites than monoclonal antibody 2G12.
Pashov A; MacLeod S; Saha R; Perry M; VanCott TC; Kieber-Emmons T
Glycobiology; 2005 Oct; 15(10):994-1001. PubMed ID: 15917430
[TBL] [Abstract][Full Text] [Related]
17. Evolution and variation of the H3 gene of influenza A virus and interaction among hosts.
Zhang W; Jiang Q; Chen Y
Intervirology; 2007; 50(4):287-95. PubMed ID: 17622733
[TBL] [Abstract][Full Text] [Related]
18. The amino acid following an asn-X-Ser/Thr sequon is an important determinant of N-linked core glycosylation efficiency.
Mellquist JL; Kasturi L; Spitalnik SL; Shakin-Eshleman SH
Biochemistry; 1998 May; 37(19):6833-7. PubMed ID: 9578569
[TBL] [Abstract][Full Text] [Related]
19. Phylogeny-aware gap placement prevents errors in sequence alignment and evolutionary analysis.
Löytynoja A; Goldman N
Science; 2008 Jun; 320(5883):1632-5. PubMed ID: 18566285
[TBL] [Abstract][Full Text] [Related]
20. Vpu-mediated CD4 down-regulation and degradation is conserved among highly divergent SIV(cpz) strains.
Gomez LM; Pacyniak E; Flick M; Hout DR; Gomez ML; Nerrienet E; Ayouba A; Santiago ML; Hahn BH; Stephens EB
Virology; 2005 Apr; 335(1):46-60. PubMed ID: 15823605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]